Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
New results suggest a link
| The first 150 words of the full text of this article appear below. |
Is there an increased risk of upper gastrointestinal bleeding associated with antidepressant therapy? Most clinicians probably think this unlikely. Indeed, despite spontaneous case reports,1-3 most drug reference sources, including the British National Formulary and the Data Sheet Compendium, do not mention any such association. In this issue, however, de Abajo et al report that there is indeed an increased risk with selective serotonin reuptake inhibitors (p 1106).4 Moreover, they suggest a possible interaction with non-steroidal anti-inflammatory agents, leading to an increased risk far beyond a simple additive effect. How robust are these results and what are the implications for clinical practice?
Retrospective observational studies are always subject to confounding,
and the present case-control study is no exception. However, this study
seems to be less prone to it. Upper gastrointestinal bleeding is not
generally known to be associated with serotonin reuptake inhibitors, so
channelling bias5 is less likely. The